News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
29,221 Results
Type
Article (3959)
Company Profile (6)
Press Release (25256)
Multimedia
Podcasts (20)
Webinars (3)
Section
Business (10470)
Career Advice (100)
Deals (1549)
Drug Delivery (14)
Drug Development (4067)
Employer Resources (15)
FDA (851)
Job Trends (867)
News (16480)
Policy (1567)
Tag
Academia (112)
Accelerated approval (1)
Adcomms (2)
Allergies (8)
Alliances (2310)
ALS (16)
Alzheimer's disease (33)
Antibody-drug conjugate (ADC) (12)
Approvals (836)
Artificial intelligence (21)
Autoimmune disease (8)
Automation (2)
Bankruptcy (15)
Best Places to Work (538)
BIOSECURE Act (2)
Biosimilars (22)
Biotechnology (4)
Bladder cancer (3)
Brain cancer (2)
Breast cancer (30)
Cancer (155)
Cardiovascular disease (30)
Career advice (81)
Career pathing (2)
CAR-T (18)
CDC (8)
Cell therapy (40)
Cervical cancer (1)
Clinical research (3178)
Collaboration (71)
Compensation (24)
Complete response letters (4)
COVID-19 (356)
CRISPR (2)
C-suite (86)
Data (136)
Depression (3)
Diabetes (14)
Diagnostics (143)
Digital health (1)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (16)
Drug pricing (39)
Drug shortages (1)
Duchenne muscular dystrophy (6)
Earnings (2895)
Editorial (11)
Employer branding (7)
Employer resources (14)
Events (2711)
Executive appointments (103)
FDA (946)
Frontotemporal dementia (1)
Funding (80)
Gene editing (7)
Generative AI (2)
Gene therapy (44)
GLP-1 (67)
Government (375)
Guidances (27)
Healthcare (613)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (24)
Immuno-oncology (9)
Indications (1)
Infectious disease (364)
Inflammatory bowel disease (1)
Inflation Reduction Act (3)
Influenza (8)
Intellectual property (2)
Interviews (17)
IPO (488)
IRA (14)
Job creations (335)
Job search strategy (76)
JPM (15)
Labor market (11)
Layoffs (78)
Leadership (4)
Legal (408)
Liver cancer (3)
Longevity (2)
Lung cancer (15)
Lymphoma (7)
Machine learning (1)
Management (3)
Manufacturing (53)
MASH (6)
Medical device (318)
Medtech (320)
Mergers & acquisitions (1096)
Metabolic disorders (54)
Multiple sclerosis (11)
Neurodegenerative disease (21)
Neuropsychiatric disorders (5)
Neuroscience (97)
NextGen: Class of 2026 (302)
Non-profit (105)
Now hiring (6)
Obesity (32)
Opinion (47)
Pain (5)
Pancreatic cancer (2)
Parkinson's disease (3)
Partnered (1)
Patents (18)
Patient recruitment (14)
Peanut (5)
People (4718)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase 1 (930)
Phase 2 (1421)
Phase 3 (1338)
Pipeline (169)
Policy (53)
Postmarket research (178)
Preclinical (343)
Press Release (1)
Prostate cancer (17)
Psychedelics (2)
Radiopharmaceuticals (45)
Rare diseases (30)
Real estate (276)
Recruiting (6)
Regulatory (1009)
Reports (4)
Research institute (113)
Resumes & cover letters (24)
Rett syndrome (1)
RNA editing (1)
RSV (3)
Schizophrenia (9)
Series A (17)
Series B (16)
Sickle cell disease (4)
Special edition (6)
Spinal muscular atrophy (41)
Sponsored (4)
Startups (352)
Stomach cancer (1)
Supply chain (9)
Tariffs (25)
The Weekly (20)
Vaccines (126)
Venture capital (21)
Weight loss (21)
Women's health (3)
Date
Last 7 days (19)
Last 30 days (66)
Last 365 days (1022)
2026 (95)
2025 (1053)
2024 (1347)
2023 (1381)
2022 (3315)
2021 (2709)
2020 (2269)
2019 (1812)
2018 (1392)
2017 (1681)
2016 (1299)
2015 (1489)
2014 (1161)
2013 (904)
2012 (1048)
2011 (1020)
2010 (1021)
Location
Africa (59)
Alabama (3)
Arizona (5)
Asia (1645)
Australia (247)
California (299)
Canada (170)
China (33)
Colorado (7)
Connecticut (11)
Delaware (12)
Europe (5937)
Florida (27)
Georgia (4)
Idaho (3)
Illinois (14)
Indiana (15)
Iowa (1)
Japan (4)
Kansas (4)
Kentucky (1)
Maryland (65)
Massachusetts (245)
Michigan (4)
Minnesota (6)
Nebraska (1)
Nevada (6)
New Hampshire (7)
New Jersey (87)
New Mexico (1)
New York (54)
North Carolina (46)
Northern California (164)
Ohio (8)
Oregon (1)
Pennsylvania (41)
Puerto Rico (1)
Rhode Island (2)
South America (85)
South Carolina (1)
South Dakota (1)
Southern California (91)
Tennessee (2)
Texas (19)
United States (939)
Utah (3)
Virginia (5)
Washington D.C. (3)
Washington State (14)
Wisconsin (2)
29,221 Results for "nova".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Centinel Spine® Receives MDR Certification for prodisc® C Vivo and prodisc® C Nova Cervical Total Disc Replacement Systems
September 12, 2025
·
3 min read
Press Releases
UB Neurosurgery and Ambulatory Neurosurgery Center (ANSC™) in partnership with NOVA Neuro, Awarded First-of-Its-Kind Grant to Decode Brain Aneurysm Risk Powered by Artificial Intelligence
August 6, 2025
·
3 min read
Press Releases
Patricia Industries’ subsidiary Advanced Instruments to acquire and merge with Nova Biomedical
March 19, 2025
·
5 min read
Press Releases
DEBRA Research Announces Impact Investment into Nova Anchora to Advance Protein Therapy for Epidermolysis Bullosa
April 29, 2025
·
5 min read
Press Releases
Galera Therapeutics completes acquisition of Nova Pharmaceuticals
December 31, 2024
·
7 min read
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
Dexcom, Inc., a global leader in real-time continuous glucose monitoring for people with diabetes, announced that residents of Nova Scotia living with either type 1 or type 2 diabetes who use intensive insulin and meet eligibility criteria now have coverage for Dexcom G6 and Dexcom G7 continuous glucose monitoring systems.
June 3, 2024
·
4 min read
Press Releases
Nova Scotia shows leadership in publicly reimbursing Pluvicto™ for eligible patients with advanced prostate cancer
February 4, 2025
·
4 min read
Press Releases
Truvian Health Appoints Dr. Tina Nova to its Board of Directors
December 11, 2024
·
2 min read
Press Releases
Proteomics Market to Reach USD 95.81 Billion to 2034 - Exclusive Report by Nova one advisor
February 7, 2025
·
1 min read
Policy
Nova Mentis Applauds Government Decision to Create Rare Disease Advisory Group
Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is pleased the Canadian government has established a new Implementation Advisory Group
November 3, 2023
·
3 min read
1 of 2,923
Next
